ProStrakan completes Fortigel study, plans FDA filing in Q3
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
ProStrakan completes Fortigel study, plans FDA filing in Q3
8 May 08, 06:57
LONDON (Thomson Financial) - Pharmaceutical company ProStrakan Plc. said it has successfully completed a clinical trial for Fortigel, ...
more

 

 
© 2007 nafdacnigeria.org